REBECCA BREWSTER: Open Payments
NPI 1144658527 · WAVERLY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 113 payments from 12 companies in 2025. Trend: 2023 $1,490 · 2024 $1,729 · 2025 $1,692
Food & beverage: $1,620Education: $71
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $319 |
| Otsuka America Pharmaceutical, Inc. | 18 | $240 |
| ABBVIE INC. | 23 | $198 |
| Vanda Pharmaceuticals Inc. | 8 | $168 |
| Alkermes, Inc. | 14 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $136 |
| Neurocrine BioSciences, Inc. | 7 | $130 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| Axsome Therapeutics, Inc. | 4 | $64 |
Products named: VRAYLAR, ARISTADA, REXULTI, UZEDY, CAPLYTA, INGREZZA, AUSTEDO XR, HETLIOZ.
Industry payments across OH — which companies pay providers there.
